Search results

  1. P

    Comparing DNA Methylation Landscapes in Peripheral Blood from [ME/CFS] and Long COVID Patients, 2025, Peppercorn et al

    Thank you for the warm welcome. I couldn’t find the thing you mentioned that the LC patients are Post COVID 19 ME/CFS patients, as to my understanding from the paper, the Long COVID patients are different and never had ME before, but obviously we can ask Dr. Tate for a confirmation? i have a...
  2. P

    Comparing DNA Methylation Landscapes in Peripheral Blood from [ME/CFS] and Long COVID Patients, 2025, Peppercorn et al

    It It would be interesting to get hold of the 70000 data to see what the results so for PCA, however my understanding would be that the paper is just a small study and we all are too hyped up about this. I would give the authors benefit of the doubt and let the manuscript be peer reviewed and...
  3. P

    Comparing DNA Methylation Landscapes in Peripheral Blood from [ME/CFS] and Long COVID Patients, 2025, Peppercorn et al

    I think there has been a mistake interpreting this, I think it says that the three authors mentioned here are funded by the ANZMES and donations from the families and other resources as well, not that the three authors part funded the study. This seems more logical though.
  4. P

    Comparing DNA Methylation Landscapes in Peripheral Blood from [ME/CFS] and Long COVID Patients, 2025, Peppercorn et al

    I read some other papers on methylome analysis in cancer and other diseases and it is always expected to work with significant fragments that pass a certain P value criteria or FDR criteria (in larger sample number) to avoid the noises or false fragments. As per the manuscript in this one says...
Back
Top Bottom